Esther Bullitt Selected Research

Esther Bullitt Research Topics

5	Infections 01/2022 - 02/2010
4	Diarrhea 01/2021 - 02/2008
3	COVID-19 01/2021 - 08/2020
3	Cysts 01/2012 - 07/2009
1	Hepatitis 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Flavivirus Infections 01/2022
1	Nausea 01/2021
1	Virus Diseases (Viral Diseases) 10/2015
1	Urinary Tract Infections (Urinary Tract Infection) 12/2013
1	Intestinal Diseases (Diseases, Intestinal) 02/2008
1	Atherosclerosis 10/2006

4	Proteins (Proteins, Gene)FDA Link 08/2010 - 10/2006
2	CholesterolIBA 01/2022 - 10/2006
2	Viral RNAIBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 12/2020 - 08/2020
2	AntibodiesIBA 09/2015 - 12/2013
2	AntigensIBA 02/2012 - 02/2008
2	ChitinIBA 01/2012 - 07/2009
2	LectinsIBA 08/2010 - 07/2009
1	remdesivirIBA 01/2022
1	camostatIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Interferon Type IIBA 01/2022
1	InterferonsIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	VaccinesIBA 01/2017
1	LipidsIBA 10/2015
1	Virulence Factors (Pathogenicity Factors)IBA 02/2012
1	PolymersIBA 01/2012
1	HydrolasesIBA 01/2012
1	SugarsIBA 01/2012
1	glucan synthaseIBA 01/2012
1	GlucansIBA 01/2012
1	AlkaliesIBA 08/2010
1	Chymotrypsin FDA Link 08/2010
1	AcetylgalactosamineIBA 08/2010
1	ChitinasesIBA 07/2009
1	PhalloidineIBA 07/2009
1	Maltose-Binding ProteinsIBA 07/2009
1	SuspensionsIBA 07/2009
1	DAPIIBA 07/2009
1	Nucleic AcidsIBA 07/2009
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2006
1	Apolipoproteins B (ApoB)IBA 10/2006

1	Oral Administration 09/2015